Filter by: patients
What is Glatiramer acetate?

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 3996 1292 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 115 24 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
General health 57 25 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Stiffness/Spasticity 29 3 Efficacy_none Efficacy_cant_tell
Fatigue 25 10 Efficacy_major Efficacy_slight Efficacy_none Efficacy_cant_tell
Don't know 19 5 Efficacy_slight Efficacy_cant_tell

See all 3362 patients currently taking Glatiramer acetate

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
153
Moderate
219
Mild
639
None
338

Commonly reported side effects, conditions, and hospitalizations associated with Glatiramer acetate

Injection site reaction 326
Lumps and bumps 286
Injection site itching 256
Injection site pain 242
Redness 240
Bruising 160
See all 279 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Glatiramer acetate. See all 45 dosages

  daily 1 mg daily 1 mL daily 20 mg weekly 20 mg every other day 10 mg daily 20 mg daily 30 mg daily 40 mg daily 200 mg daily
  213 Number of Patients: 213 40 Number of Patients: 40 9 Number of Patients: 9 8 Number of Patients: 8 137 Number of Patients: 137 13 Number of Patients: 13 2843 Number of Patients: 2843 6 Number of Patients: 6 13 Number of Patients: 13 8 Number of Patients: 8  

Reported Stop Reasons

Why Patients Stopped Taking Glatiramer acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 637   Did not seem to work: 39%
Side effects too severe 538   Side effects too severe: 33%
Doctor's advice 447   Doctor's advice: 27%
Other 331   Other: 20%
Expense 128   Expense: 8%
Personal research 99   Personal research: 6%
Change in health plan coverage 51   Change in health plan coverage: 3%
Course of treatment ended 25   Course of treatment ended: 2%
Not indicated 25   Not indicated: 2%

See all 1568 patients who’ve stopped taking Glatiramer acetate

Currently Taking Glatiramer acetate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Glatiramer acetate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Glatiramer acetate

Always
1019 76%
Usually
270 20%
Sometimes
36 3%
Never
24 2%

Burden

Difficulty being on treatment

Burden of Glatiramer acetate

Very
128 9%
Somewhat
295 22%
A little
495 37%
Not at all
431 32%

Cost

Paid out of pocket

Cost of Glatiramer acetate

$200+
109 11%
$100-199
67 7%
$50-99
106 10%
$25-49
240 23%
< $25
487 48%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 09, 2012.